OCU400
AXP000262.1 · Viral vector gene therapy
- Platform
- AAV5 vector
- Targets
- NR2E3
- Originator
- Ocugen
- Sponsor
- Ocugen
Names
Virus
- Role
- In vivo gene transfer
- Family
- Parvoviridae
- Virus
- adeno-associated virus 5
- Strain
- AAV5
- Replication
- non replicating
- Transgenes
- NR2E3
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (3)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT06388200 | A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa | Active not recruiting | Phase 3 | 2024-06-18 | 2027-02-12 | 140 | Retinitis Pigmentosa |
| NCT05203939 | Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis | Active not recruiting | Phase 1/2 | 2022-01-24 | 2027-03 | 22 | Leber Congenital Amaurosis; Retinitis Pigmentosa |
| NCT06574997 | Expanded Access Program for RP in Adults | No longer available | Retinitis Pigmentosa |
Recent changes
No changes recorded in its trials yet.
Clinical papers
No confirmed clinical papers yet.
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 40869487 | Genetic Therapies for Retinitis Pigmentosa: Current Breakthroughs and Future Directions. | Journal of clinical medicine | 2025 | name in abstract: OCU400 |
| PMID 41234928 | Preclinical biodistribution and toxicology assessment of an AAV5-based subretinal modifier gene therapy for retinitis pigmentosa. | Frontiers in medicine | 2025 | name in abstract: OCU400 |
Notes
Modifier gene therapy delivering the nuclear hormone receptor gene NR2E3 (AAV.hNR2E3) for retinitis pigmentosa, taken gene-agnostically as well as for RHO-associated disease. Phase 1/2 NCT05203939 and phase 3 liMeliGhT NCT06388200, which completed enrolment of 140 patients in March 2026 and is meant to support a BLA. Route not taken from a primary source here, so `route` is empty.
How to cite
OCU400 (AXP000262.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000262.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.